Decoy Therapeutics (DCOY) Return on Sales [ROS] (2016 - 2026)
Decoy Therapeutics' Return on Sales [ROS] came in at -1155.84% for Q2 2026.
Powered by 
Analysis
Decoy Therapeutics (DCOY) Return on Sales [ROS] (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Decoy Therapeutics reported Return on Sales [ROS] of -6521.34%; for FY2021, it came in at -696.27%, down 547.49 percentage points from FY2020.
- Return on Sales [ROS] carries a five-year change of +3250.27 percentage points (FY2016 to FY2021).
- Going back by year, Return on Sales [ROS] was -148.78% in FY2020 (+89.74 pp), -238.53% in FY2019 (-152.20 pp), -86.33% in FY2018 (+2638.32 pp) and -2724.65% in FY2017 (+1221.89 pp).
- The Q2 2026 figure represents the highest quarterly Return on Sales [ROS] since Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Decoy Therapeutics | 941,583.35 | 941,583.35 | - | -1,155.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,155.84% |
| Mar 31, 2022 | -2,997.19% |
| Dec 31, 2021 | -696.27% |
| Sep 30, 2021 | -314.10% |
| Jun 30, 2021 | -545.48% |
| Mar 31, 2021 | -142.23% |
| Dec 31, 2020 | -118.82% |
| Sep 30, 2020 | -127.59% |
| Jun 30, 2020 | -152.89% |
| Mar 31, 2020 | -209.17% |
| Dec 31, 2019 | -198.33% |
| Sep 30, 2019 | -429.76% |
| Jun 30, 2019 | -101.82% |
| Mar 31, 2019 | -233.79% |
| Dec 31, 2018 | -1,239.45% |
| Sep 30, 2018 | -66.84% |
| Jun 30, 2018 | -3,708.19% |
| Mar 31, 2018 | -4,638.10% |
| Dec 31, 2017 | -2,861.44% |
| Sep 30, 2017 | -2,275.01% |
API Access
Decoy Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=DCOY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "DCOY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=DCOY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();